India's Biocon plans IPO for biosimilars business by March 2026 February 1, 2025 Indian biopharma company Biocon reported third-quarter revenue on Thursday that fell about 3% when compared with ...

India's Biocon plans IPO for biosimilars business by March 2026 February 1, 2025 Biopharmaceutical company Biocon's unit Biocon Biologics will sell its Indian branded formulations businesses to ...